Vincent F. S. Dubois

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

Paul Baverel, Vincent F. S. Dubois, Chao Yu Jin et al. · Clinical Pharmacology & Therapeutics · 2017 · 151 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Identifying the translational gap in the evaluation of drug‐induced <scp>QT_c</scp> interval prolongation

Anne Chain, Vincent F. S. Dubois, Meindert Danhof et al. · British Journal of Clinical Pharmacology · 2013 · 31 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and Humans

Vincent F. S. Dubois, Wilhelmus E. A. de Witte, Sandra A. G. Visser et al. · Pharmaceutical Research · 2015 · 24 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results

Andrea L. Vavere, Marvin Sinsakul, Emily L. Ongstad et al. · Journal of the American Heart Association · 2023 · 21 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

19O Preliminary safety, antitumor activity and pharmacodynamics results of HIT-IT MEDI1191 (mRNA IL-12) in patients with advanced solid tumours and superficial lesions

Omid Hamid, Matthew Hellman, Benedito A. Carneiro et al. · Annals of Oncology · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +13